Amyotrophic Lateral Sclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Subgroup analysis based on ALS site of onset revealed an association between ERCC6L2 rs591486 and ALS with limb onset.
|
30879219 |
2019 |
Developmental delay (disorder)
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Bone marrow failure without developmental delay or microcephaly with ERCC6L2 mutation has not been previously described.
|
28815563 |
2018 |
Global developmental delay
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Bone marrow failure without developmental delay or microcephaly with ERCC6L2 mutation has not been previously described.
|
28815563 |
2018 |
Inherited bone marrow failure syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
ERCC6L2-associated inherited bone marrow failure syndrome.
|
29633571 |
2018 |
Parkinson Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A recent study supports that rs591486 across the ERCC6L2 gene and exposure to pesticides seem to have a joint effect on the development of Parkinson's disease, a disease which shares a few common characteristics with ALS.
|
30879219 |
2019 |
Parkinson Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Top results in the SNP-level tests provided suggestive evidence (P < 5.0E-06) that the effect of pesticide exposure on PD risk may be modified by SNPs in the ERCC6L2 gene (P = 2.4E-06), which was also supported by suggestive evidence in the gene-level analysis (P = 4.7E-05).
|
27545685 |
2016 |
Pancytopenia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Biallelic variants in the ERCC excision repair 6 like 2 gene (<i>ERCC6L2</i>) are known to cause bone marrow failure (BMF) due to defects in DNA repair and mitochondrial function.
|
29987015 |
2018 |
Pancytopenia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Bone marrow failure without developmental delay or microcephaly with ERCC6L2 mutation has not been previously described.
|
28815563 |
2018 |
Pancytopenia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Collectively, these observations identify a distinct bone-marrow-failure syndrome due to mutations in ERCC6L2, a gene implicated in DNA repair and mitochondrial function.
|
24507776 |
2014 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.
|
30804560 |
2019 |
Smoking
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
|
26053186 |
2015 |
Smoking Behaviors
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
|
26053186 |
2015 |
QT interval feature (observable entity)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of electrocardiographic parameters identifies a new association for PR interval and confirms previously reported associations.
|
25055868 |
2014 |
Anxiety
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of co-occurring anxiety in major depression.
|
24047446 |
2013 |
Major Depressive Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of co-occurring anxiety in major depression.
|
24047446 |
2013 |
Anemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Leukopenia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Thrombocytopenia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bone marrow hypocellularity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neonatal Hypotonia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Bone marrow failure without developmental delay or microcephaly with ERCC6L2 mutation has not been previously described.
|
28815563 |
2018 |
Microcephaly
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Inherited acute myeloid leukemia
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
ERCC6L2 defines a novel entity within inherited acute myeloid leukemia.
|
30936069 |
2019 |
Bone Marrow failure syndromes
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|